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Abstract The chemical composition of surgical smoke, a
gaseous by-product of some surgical devices—lasers, drills,
vessel sealing devices—is of great interest due to the many
toxic components that have been found to date. For the first
time, surgical smoke samples collected during routine key-
hole surgery were analyzed with infrared laser spectroscopy.
Traces (ppm range) of methane, ethane, ethylene, carbon
monoxide and sevoflurane were detected in the samples
which consisted mostly of carbon dioxide and water vapor.
Except for the anaesthetic sevoflurane, none of the com-
pounds were present at dangerous concentrations. Negative
effects on the health of operation room personnel can be ex-
cluded for many toxic compounds found in earlier studies,
since their concentrations are below recommended exposure
limits.
1 Introduction
The combustion and pyrolysis of biological tissue with heat-
generating surgical equipment—lasers, ultrasonic scalpels,
high-frequency electroknives and high-speed drills and
saws—produces an unwanted by-product called surgical
smoke [1]. Surgical smoke has been shown to contain hun-
dreds of chemical species, many of which are toxic or
carcinogenic [1–15]. Moreover, surgical smoke is a viable
transport mechanism for viruses [16–20], blood- and cell-
containing aerosols [20–22] and tissue fragments [23]. Al-
though reports of infections transmitted via surgical smoke
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are rare [17, 18], the risk is not zero. Due to its potential
toxicity to both operation room (OR) personnel and pa-
tients, knowledge about the chemical, biological and par-
ticulate composition of surgical smoke is of great interest.
Recent studies of surgical smoke gathered in vivo relied on
selected ion flow tube–mass spectrometry (SIFT-MS) [24]
and gas chromatography–mass spectrometry (GC-MS) [25–
27]. These techniques are very sensitive and selective, but
obtaining the concentration values necessary for risk assess-
ment requires tedious calibrations. The detected compounds
were mainly aromatic hydrocarbons, alkenes, alkanes, alde-
hydes and ketones; a selection thereof is given in Table 1.
In particular, benzene and formaldehyde, two known car-
cinogens [28, 29], have been detected in surgical smoke at
concentrations in the parts-per-billion (ppb) range [25].
Infrared laser spectroscopy, which probes the rovibra-
tional structure of molecules, is a popular technique for the
detection and quantification of trace amounts of molecu-
lar species. Its advantages include high sensitivity, selec-
tivity, dynamical range and fast time response [30–39]. Al-
though some applications profit from sample pretreatment
(e.g. removal of water and carbon dioxide, preconcentra-
tion with cryo or thermal desorption traps), these steps are
usually not necessary. Furthermore, concentrations can eas-
ily be computed given the measured transmittance or ab-
sorbance values and absorption cross sections. In this article
we present a study of the chemical composition of surgical
smoke obtained during routine colorectal keyhole (laparo-
scopic) surgery at the University Hospital Zurich (USZ). In
contrast to open surgery, where surgical smoke is produced
in an oxygen–nitrogen atmosphere, in laparoscopy the tis-
sue pyrolysis takes place in a carbon dioxide atmosphere.
Moreover, toxic compounds are not released into the atmo-
sphere, but remain trapped within the abdominal cavity of
the patient, from where they can be absorbed into the blood
circulation.
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Table 1 Selection of chemical compounds detected in surgical smoke
Name CAS no. Refs.
Toluene 108-88-3 [1–14, 25, 26, 80]
Ethylbenzene 100-41-4 [1–12, 14, 25, 26]
Styrene 100-42-5 [1, 5–8, 10–14, 25]
Benzene 71-43-2 [1, 6–9, 12–14, 25]
Acrylonitrile 107-13-1 [1, 4, 5, 8, 13, 25, 27]
1-Undecene 821-95-4 [1–3, 6, 7, 26]
1-Decene 872-05-9 [1, 3, 6, 7, 26, 80]
p-Xylene 106-42-3 [2, 6, 7, 25, 26]
m-Xylene 108-38-3 [2, 6, 7, 25, 26]
Furfural 98-01-1 [1–3, 7, 80]
Propanenitrile 107-12-0 [4, 5, 13, 80]
Hydrogen cyanide 74-90-8 [1, 12, 24, 81]
Propylbenzene 103-65-1 [2, 6, 7, 26]
Isobutene 115-11-7 [1, 13, 27, 80]
1-Heptene 592-76-7 [6, 7, 25, 80]
1,3-Butadiene 106-99-0 [1, 24, 27, 80]
Carbon monoxide 630-08-0 [1, 12, 25, 81]
Propene 115-07-1 [1, 13, 25, 27]
Ethylene 74-85-1 [1, 13, 80]
Methylthiocyanate 556-64-9 [6, 7, 80]
1-Dodecene 112-41-4 [6, 7, 26]
1-Tetradecene 1120-36-1 [6, 7, 26]
Acetylene 74-86-2 [1, 13, 24]
o-Xylene 95-47-6 [6, 25, 26]
3-Methylstyrene 100-80-1 [2, 80]
1-Dodecane 112-40-3 [2, 26]
1-Undecane 1120-21-4 [2, 26]
Name CAS no. Refs.
Pentadecane 629-62-9 [6, 26]
Tetradecane 629-59-4 [2, 26]
Decane 124-18-5 [2, 26]
Formaldehyde 50-00-0 [1, 25]
1-Butene 106-98-9 [1, 25]
Acetone 67-64-1 [7, 25]
1-Pentene 109-67-1 [25, 27]
Heptanal 111-71-7 [26]
Nonanal 124-19-6 [26]
Cyclohexanone 108-94-1 [26]
Perchloroethylene 127-18-4 [26]
Tridecane 629-50-5 [26]
Ammonia 7664-41-7 [80]
1-Hexene 592-41-6 [25]
Isooctane 540-84-1 [25]
Propadiene 463-49-0 [27]
Vinylacetylene 689-97-4 [27]
Mercaptomethane 74-93-1 [27]
Ethylacetylene 107-00-6 [27]
Diacetylene 460-12-8 [27]
Ethanol 64-17-5 [27]
Piperylene 540-60-9 [27]
Propenylacetylene 2206-23-7 [27]
1,4-Pentadiene 591-93-5 [27]
Cyclopentadiene 542-92-7 [27]
Butyrolactone 96-48-0 [27]
2 Experimental
Two infrared laser spectrometers and a Fourier-transform in-
frared (FTIR) spectrometer were used to measure the ab-
sorption spectra of surgical smoke.
2.1 Mid-IR (MIR) difference frequency generation (DFG)
laser spectrometer
Difference-frequency generation (DFG) [40] was employed
to produce laser radiation near 3000 cm−1, the fundamen-
tal C–H stretch vibration region. The experimental setup
is shown in Fig. 1 and is described in detail elsewhere
[41, 42]. Briefly, a tunable continuous wave (cw) exter-
nal cavity diode laser (ECDL) emitting at 1520–1600 nm
(Santec Corp., model TSL-210, Japan) and a Q-switched
Nd:YAG laser (InnoLight GmbH, model M800, Germany)
emitting 5-ns pulses with 5–10 kHz repetition rate at a wave-
length of 1064.55 nm are mixed in a 5-cm-long periodi-
cally poled lithium niobate (PPLN) crystal with eight dif-
ferent poling periods. The output power of the ECDL is
about 5 mW, whereas the average power of the Nd:YAG
laser is around 150–300 mW (peak power: 5 kW). The
generated idler beam is pulsed with about 150 µW of av-
erage power, a line width of 150 MHz and is tunable be-
tween 2815 and 3144 cm−1 using two different poling pe-
riods of the PPLN crystal. Part of the idler beam is directed
to a thermoelectrically cooled (HgCdZn)Te detector (Vigo
Systems SA, model PDI-2TE-4/VPDC-0.1i) for power nor-
malization. A Herriott-type home-built 35-m multipass cell
(MPC) [43] holds the sample under investigation. The idler
beam is guided into and out of the multipass cell through
the same window. A second identical detector measures the
power transmitted through the sample in the multipass cell.
A measurement of the ‘empty’ (evacuated or filled with
some non-absorbing gas such as nitrogen or a rare gas) mul-
tipass cell provides the baseline of the system. This baseline
contains fringe patterns that cannot be accurately described
over the entire tuning range of the spectrometer (329 cm−1)
with simple functions (polynomials, sine/cosine, . . .). Fur-
thermore, the fringe patterns are not stationary over more
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Fig. 1 Schematic drawing of the mid-IR difference-frequency-
generation-based laser spectrometer: (1) cw external cavity diode laser;
(2) wavemeter for ECDL; (3) polarization-maintaining (PM) fiber with
fiber coupler; (4) fiber output coupler; (5) f = 400 mm lens; (6) half-
wave plate; (7) dichroic mirror; (8) Si photodiode; (9) Q-switched
Nd:YAG laser; (10) half and quarter-wave plates; (11) f = 200 mm
lens; (12) mirrors; (13) f = 75 mm lens; (14) crystal oven with peri-
odically poled lithium niobate (PPLN) crystal; (15) f = 99 mm CaF2
lens; (16) germanium filter; (17) f = 379 mm CaF2 lens; (18) variable-
diameter aperture; (19) CaF2 beam splitter; (20) f = 200 mm CaF2
lens; (21) reference detector; (22) f = 300 mm CaF2 lens; (23) multi-
pass cell (MPC, max. path length 35 m); (24) f = 100 mm CaF2 lens;
(25) transmission detector; (26) valves; (27) connection to gas bottles
(nitrogen, carbon dioxide); (28) connection to sample bags; (29) pres-
sure gauge; (30) turbopump; (31) rotary pump
than a few hours. Hence, every sample measurement must be
followed (or preceded) by a baseline measurement. The ratio
of the two measurements then provides the sample transmit-
tance T :
T = Q
B
, (1)
where Q is the detector signal ratio of the sample measure-
ment,
Q ≡ transmitted power
reference power
, (2)
and B is the detector signal ratio of the corresponding base-
line measurement.
Tuning of the DFG source occurs by simultaneously
changing the PPLN crystal temperature and the signal laser
wavelength [41]. This technique improves the reproducibil-
ity of the measurements by forcing the PPLN crystal tem-
perature and laser wavelength to follow the same predefined
timetable during each measurement, and by keeping the scan
duration as short as possible. For example, a wavelength
scan from 2900 to 3144 cm−1 requires tuning of the sig-
nal laser wavelength from 1540 to 1600 nm and increasing
the PPLN temperature from 40 to 173°C. Due to the large
temperature change, this procedure cannot be made arbitrar-
ily fast. In the example above, the measurement takes just
over an hour if the PPLN crystal temperature is increased
at 2°C/min. The second measurement can only be started
once the initial temperature of the PPLN crystal has been
re-established, which takes 30 to 45 min. Hence, about 1.5 h
elapse between the starts of the first and second measure-
ments.
The detector signal ratio Q of the MPC filled with ar-
gon (purity 4.8) at a fixed wavelength and at a pressure
of 964 mbar was measured over 7 h. The Allan plot [44]
for this data is given in Fig. 2. It is apparent that aver-
aging for longer than about 0.2 s only slightly decreases
the (relative) Allan deviation σ (A)Q /Q from its initial value
of 0.05%. This value would imply a sensitivity of αmin =
1.4 × 10−7 cm−1 (for 35 m path length). Better sensitivi-
ties down to 4 × 10−8 cm−1 can be achieved at wavelengths
where more idler power is available. However, as a second
measurement (the baseline B , taken 1.5 h later) is required
to obtain transmittance values (see (1)), any drifts occurring
during this time will introduce an error in the transmittance.
The sensitivity of the system can be estimated by comparing
two measurements A1 and A2, both with averaging time τ ,
taken 1.5 h apart at the same wavelength. The square root of
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Fig. 2 Relative Allan deviation plot for the detector signal ratio
(see (2)) measured at a constant wavelength and PPLN crystal tem-
perature over 7 h
the general two-sample variance σ 2Q(N,T , τ) [44, 45] with
N = 2, T = 1.5 h and τ = 0.2 s,
σ 2Q ≡
1
2
(A1 − A2)2, (3)
is an estimator for the sensitivity of the system. Notice that
this is the same expression as for the Allan variance (Eq. (5)
in [44]), with the only difference that here A1 and A2 are not
measured immediately after one another. The uncertainty in
the transmittance can then be estimated from (1) as
σT
T
=
√(
σQ
Q
)2
+
(
σB
B
)2
≈ √2σQ
Q
= 0.7%, (4)
where σQ/Q ≡
√
σ 2Q(N = 2, T = 1.5 h, τ = 0.2 s)/Q2 =
0.5%, corresponding to a smallest measurable absorption
coefficient of αmin = 9 × 10−7 cm−1. In (4), it was assumed
that Q ≈ B and σQ ≈ σB . In Fig. 3, three consecutive base-
line measurements were divided by a previously taken mea-
surement. The expected value for the transmittance T is 1.
Root-mean-square deviations range from 0.4% to 0.7%, in
good agreement with (4). The key parameters of the spec-
trometer are summarized in Table 2.
2.2 Near-IR (NIR) spectrometer with two distributed
feedback diode lasers
Two distributed feedback (DFB) laser diodes emitting at
2323.6 nm (4303.6 cm−1) and 2433.1 nm (4110 cm−1) were
used to probe the R(12) absorption line of the ν = 2 ← 0
overtone transition of carbon monoxide (CO, line strength
2.28 × 10−21 cm/molecule) and the R(3) absorption line
of the ν = 1 ← 0 fundamental transition of hydrogen flu-
oride (HF, line strength 1.59 × 10−18 cm/molecule), re-
spectively. Both diodes were manufactured by Nanoplus
Fig. 3 Three consecutive baseline measurements divided by a fourth
measurement taken first (not shown). The expected value for the trans-
mittance T is 1. The root-mean-square (rms) of the deviation is given
in the figure
GmbH, Germany. These wavelengths are not accessible
with our MIR DFG spectrometer, nor are there any over-
tone bands of HF and CO in its tuning range. The spec-
trometer is shown in Fig. 4. Each diode is housed in
a thermoelectrically cooled laser diode mount (Thorlabs,
model TCLDM9, Germany). The beam is collimated by a
f = 12.7 mm CaF2 lens. Two silver-coated mirrors guide
the beam into the multipass cell (MPC, New Focus, model
5611, USA) through a CaF2 window. The total absorp-
tion path length was determined to be 8 m, correspond-
ing to 40 passes. The transmitted beam is focused by an
off-axis parabolic mirror (f = 100 mm) onto a thermo-
electrically cooled detector (Vigo Systems SA, model PDI-
2TE-4/VPDC-0.1i). The peak responsivity of this detec-
tor is at 4 µm, but with the available power (2–3 mW)
the signal-to-noise ratio is more than adequate even at
2.3–2.4 µm. For measurements based on the wavelength-
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modulation (WM) technique [30, 46–48], the ramp fre-
quency was 3.3 Hz and the modulation frequency was fm =
Table 2 Key parameters of the mid-IR difference-frequency-
generation-based laser spectrometer
Property Specification
Tuning rangea 2815–3144 cm−1 (3.18–3.55 µm)
Line width 150 MHz
Tuning rateb 3.67 cm−1/min
Power avg. 150 µW, peak 5 W
Absorption path length 35 m
Sensitivity αmin 9 × 10−7 cm−1
Sensitivityc αmin 4 × 10−8–4 × 10−7 cm−1
aRequires two different PPLN crystal poling periods
bHeating the PPLN crystal at 2°C/min
cIf a baseline measurement is not necessary, i.e. for measurements of
isolated absorption lines; 0.2 s averaging time
45 kHz. A lock-in amplifier (Stanford Research, model
SR830, USA) was used for measurement of the second-
harmonic amplitude (at 2fm = 90 kHz). For direct transmis-
sion measurements, the modulation was switched off and the
ramp frequency was increased to about 1 kHz. Sweep inte-
gration [49, 50] was employed in order to suppress laser
and detector 1/f -noise. The detector signal was oversam-
pled at 100 MHz with a 14-bit ADC card (Gage, model
CS14100, USA) and then decimated to increase ADC reso-
lution.
The key parameters of the spectrometer are given in Ta-
ble 3. Interference fringes are suppressed by dithering the
length of the multipass cell and the distance between the
laser diode and the collimating lens. However, it is not pos-
sible to completely remove the fringes, and the effective-
ness of the cancellation is not reproducible. The residual
fringes after 1-min averaging limit the sensitivity to about
10−8 cm−1.
Fig. 4 Upper part: photograph of the NIR laser spectrometer, with
beam path drawn in. Lower part: schematic drawing: (1) voltage ramp
generator; (2) voltage sine generator; (3) adder; (4) laser diode current
driver; (5) thermoelectrically (TE) cooled laser diode mount and DFB
laser diode A (λ = 2433.1 nm); (6) collimating CaF2 f = 12.7 mm
lens; (7) TE-cooled laser diode mount and DFB laser diode B (λ =
2323.6 nm); (8) collimating CaF2 f = 12.7 mm lens; (9) flipping mir-
ror; (10) silver-coated mirror; (11) multipass gas cell (MPC) with CaF2
window; (12) off-axis parabolic silver-coated mirror (f = 10 cm);
(13) TE-cooled HgCdZnTe detector; (14) lock-in amplifier (second-
harmonic detection); (15) oscilloscope or acquisition card; (16) valve;
(17) pressure gauge; (18) inlet for gas samples; (19) rotary vacuum
pump
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Table 3 Key parameters of the
near-IR laser spectrometer Property Specification
Diode A Diode B
Wavelength 2433.1 nm 2323.6 nm
Line width < 3 MHz < 3 MHz
Power 2 mW 3 mW
Absorption path length 8.0 m 8.0 m
Sensitivity αmin (noise-equivalent) 8.5 × 10−10 cm−1 Hz−1/2 8.5 × 10−10 cm−1 Hz−1/2
Sensitivity (actual) 1 × 10−8 cm−1 3.1 × 10−8 cm−1
Limit of detection (LOD) 110 ppt HF 250 ppb CO
2.2.1 Remark about absorption path length and number of
passes in multipass cells (MPCs)
The transmittance through a single-pass cell with length  is
given by Beer–Lambert’s law:
T = exp(−α), (5)
where α is the absorption coefficient. In a MPC, where the
beam experiences n reflections on mirrors of reflectivity R,
the transmittance becomes
Tn(α) = Rn exp
(−α(n + 1)). (6)
The most simple way to determine the absorption coefficient
on the peak of an isolated absorption line is to take a mea-
surement s0 off the absorption line, and one measurement s1
on the absorption line. Given the following expressions for
s0 and s1,
s0 = P0Tn(0) = P0Rn,
s1 = P0Tn(α) = P0Rn exp
(−α(n + 1)), (7)
with P0 the laser power incident on the MPC, the absorption
coefficient α can be computed if n,  and the ratio s1/s0 are
known:
α = − 1
(n + 1) ln
(
s1
s0
)
. (8)
The sensitivity (and precision) of the system are determined
by the standard deviation σα of α:
σα =
√
2
(n + 1)
σs
s
, (9)
where it was assumed that s0 = s1 = s (zero absorption) and
σs0 = σs1 ≡ σs (same noise in both measurements). A simple
model for σs is
σs =
√
σ 2d + σ 2l =
√
σ 2d +
(
P0κRn
)2
, (10)
where σd is the noise-equivalent power of the detector
(within a given detection bandwidth b) and σl = P0κRn is
the absolute laser power noise (within the same detection
Fig. 5 Calculated standard deviation of the absorption coefficient α
for ideal (reflectivity R = 1) and real (R = 0.99, R = 0.95) mirrors
versus number of reflections n in a multipass cell, taking into account
laser and detector noise. The minima are located at n∗ ≈ ∞, 100, 20
for R = 1, 0.99, 0.95, respectively
bandwidth b), with κ the relative intensity noise (RIN). By
inserting (10) into (9), we obtain
σα =
√
2
(n + 1)
√
η2
R2n
+ κ2, (11)
with η ≡ σd/P0. The minimum of σα can be computed by
setting its derivative with respect to n equal to zero.If κ = 0,
the expression becomes very simple: the minimum of σα is
located at
n∗ = −1
lnR
− 1. (12)
In Fig. 5, σα is plotted versus n for the arbitrary choice of
η = κ = 0 and three different mirror reflectivities. There is
no significant difference if η = κ , as long as both are differ-
ent from zero. Although the noise model (see (10)) is very
simple and does not take into account, for example, diffrac-
tion losses, interference effects (fringes), and mechanical vi-
brations, it implies that with mirrors of relatively low reflec-
tivity one should consider working with a lower number of
passes (e.g. with R = 0.97 → n∗ = 32).
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Fig. 6 Calibration of the near-IR spectrometer when used in wave-
length-modulation (WM) mode. The power-normalized amplitude
(S/P ) of the second harmonic measured at the center of the absorp-
tion line is plotted versus the absorption 1 − T . The relationship is
linear with the slopes kA and kB
2.2.2 Calibration of the NIR spectrometer
To establish the total absorption path length inside the MPC,
absorption lines of carbon monoxide (CO) and methane
(CH4) were measured at known concentrations in direct
transmission mode, i.e. without wavelength modulation. The
line parameters were taken from HITRAN [51] and the ab-
sorption path length L was used as a fit parameter. The total
absorption path length was found to be L = 8.0 ± 0.1 m.
When the spectrometer was used in direct transmission
mode, no calibration was necessary. For the measurements
carried out with wavelength modulation, the spectrometer
was calibrated by measuring the power-normalized ampli-
tude of the second harmonic at the center of the absorption
line for different concentrations of carbon monoxide and
methane. The results are shown in Fig. 6. The data points
appear paired because two methane absorption lines with
different line strengths were measured at each concentra-
tion. The relationship between the absorption 1 − T and
the power-normalized amplitude S/P is
S
P
= k(1 − T ), (13)
with kA = 0.2817 for the diode A emitting at 2433.1 nm
and kB = 0.3134 for the diode B emitting at 2323.6 nm.
These values can be used to calibrate the vertical axis in
wavelength-modulation measurements (see Fig. 9, later).
Fig. 7 Photograph taken at the University hospital Zurich (USZ) dur-
ing keyhole surgery. The electroknife is a vessel sealing device which
produces small amounts of (surgical) smoke
2.3 Fourier-transform infrared (FTIR) spectrometer
Two samples were measured with a commercial Fourier-
transform infrared (FTIR) spectrometer (Bruker Optics,
model IFS66v, USA) with a resolution of 0.125 cm−1 and
4-m absorption path length.
2.4 Sample collection
All the samples analyzed in this work originated from rou-
tine colorectal laparoscopic (keyhole) surgeries at the Uni-
versity Hospital Zurich (USZ). During the procedures, a
high frequency vessel sealing device (ValleyLab, model Lig-
aSure, USA) was employed (Fig. 7). A 3 L Tedlar® bag
(CEL Scientific, USA) was connected to one of the trocars
with a sterile gas tube. The abdominal cavity of the patient
was filled with carbon dioxide (the abdominal cavity filled
with a gas is called the pneumoperitoneum) with an over-
pressure of about 20 mbar. Whenever the vessel sealing de-
vice was active, the valve on the trocar was opened and the
small overpressure of the pneumoperitoneum filled the sam-
ple bag. Several sample bags were filled during each opera-
tion and then transported to our laboratory for analysis. The
list of measured samples is given in Table 4. Of the 33 col-
lected samples, 29 were measured with the MIR DFG spec-
trometer, six with the NIR spectrometer and two with the
FTIR spectrometer.
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Table 4 Overview of the
samples collected at the
University hospital Zurich. For
each operation (Op.) H01–H06,
several sample bags were filled
(a, b, c, . . .). The spectrometer
they were measured with is
indicated with a  in the
respective column
aMid-IR DFG spectrometer
bNear-IR spectrometer (HF, CO)
Op. Bag Content Measured with Remarks
MIRa NIRb FTIR
H01 a CO2   Medical CO2
b–e Smoke 
f Smoke  
H02 a–f Smoke 
H03 a CO2  Medical CO2 flushed through
abdominal cavity of patient
b–f Smoke 
H04 a–i Smoke 
H05 a–b Smoke 
c Smoke  
H06 a Smoke  
b–c Smoke 
3 Results
The ‘blank’ samples H01a and H03a (Table 4) were mea-
sured with the MIR spectrometer to verify that there was
no contamination of the medical CO2 gas and that the em-
ployed Tedlar® bags were suited for the task. In both sam-
ples only water vapor (0.72–0.92%) was detected.
The spectra measured with the MIR DFG spectrome-
ter were qualitatively similar for most of the 27 measured
smoke samples. The spectra were analyzed with a specially
developed algorithm [52] and a database of FTIR spectra
[53]. A typical absorption spectrum measured at room tem-
perature and ambient pressure is shown in Fig. 8. Several
absorption lines appear throughout the measured spectral
range. They belong to water vapor, methane, ethane and
ethylene (Fig. 8b). The four broader absorption features are
due to sevoflurane, a liquid volatile anaesthetic commonly
used in surgery [54]. It is inhaled by the patient during the
surgery at concentrations in the percent range, but it is un-
clear how it reaches the abdominal cavity. In an attempt to
increase the overall sensitivity of the spectrometer, about
25 L of surgical smoke were pumped through a thermal des-
orption tube filled with 2.877 g of Carboxen 569 (Supelco,
USA) and later desorbed at 270°C with 400 mL/min nitro-
gen 5.0 in a total volume of 2 L. We observed about 5 ppm
of formaldehyde, but separate measurements showed that
formaldehyde is produced when sevoflurane is exposed to
high temperatures. Moreover, the preconcentration (25 L →
2 L) had no significant impact on the sensitivity due to the
strong and broad absorption of sevoflurane, which could
hide additional species with weaker absorption. Concentra-
tions for all the identified components in the 27 measured
smoke samples (plus the two blanks H01a and H03a) are
given in Table 5.
Fig. 8 (a) Typical absorption spectrum of a surgical smoke sam-
ple measured with the mid-infrared DFG spectrometer (pressure =
950 mbar, temperature = 25°C, path length = 35 m). (b) Magnified
view of the 2970–3000 cm−1 region, where absorption lines of water
vapor, methane, ethane and ethylene are visible
With the NIR spectrometer, only carbon monoxide (CO)
and hydrogen fluoride (HF) were targeted, although water
vapor and methane could be measured as well. We hypoth-
esized that hydrogen fluoride could be generated in an at-
mosphere containing sevoflurane vapor if sufficient energy
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Table 5 Chemical composition of the 29 samples measured with the MIR DFG spectrometer
Concentrations
Samplea H2O
%
Sevob
ppm
CH4
ppm
C2H6
ppm
C2H4
ppm
H01 a 0.76 < 20 < 0.1 < 0.1 < 5
b 1.1 450 0.74 < 0.1 < 5
c 0.8 430 2.2 < 0.1 < 5
d 0.27 180 0.40 < 0.1 < 5
e 0.94 120 1.1 < 0.1 < 5
f 0.59 150 < 0.1 < 0.1 < 5
H02 a 0.72 290 0.70 < 0.1 < 5
b 0.53 180 0.45 < 0.1 < 5
c 0.65 160 0.39 < 0.1 < 5
d 0.68 120 2.2 0.19 < 5
e 0.58 240 5.3 1.1 6.3
f 0.58 300 9.1 2.0 10
H03 a 0.98 < 20 < 0.1 < 0.1 < 5
b 0.79 < 20 1.1 < 0.1 < 5
c 0.68 < 20 1.3 < 0.1 < 5
Concentrations
Sample H2O
%
Sevo
ppm
CH4
ppm
C2H6
ppm
C2H4
ppm
(H03) d 0.89 < 20 < 0.1 < 0.1 < 5
e 0.83 < 20 1.3 < 0.1 < 5
f 0.78 < 20 0.45 < 0.1 < 5
H04 a 0.89 56 < 0.1 < 0.1 < 5
b 0.61 59 < 0.1 < 0.1 < 5
c 0.60 78 < 0.1 < 0.1 < 5
d 0.44 110 0.15 < 0.1 < 5
e 0.58 80 0.22 < 0.1 < 5
f 0.59 130 < 0.1 < 0.1 < 5
g 0.45 110 < 0.1 < 0.1 < 5
h 0.55 69 0.16 < 0.1 < 5
i 0.60 87 0.15 < 0.1 < 5
H05 c 0.99 250 34 < 0.1 < 5
H06 a 0.47 < 20 < 0.1 < 0.1 < 5
aFor a description of the samples, see Table 4
bSevoflurane C4H3F7O (CAS no. 28523-86-6)
Fig. 9 Second-harmonic amplitude of the CO absorption line at
2323.6 nm measured in three surgical smoke samples
(heat) was provided. Indeed, an electrical discharge with a
medical monopolar electroknife in a sevoflurane vapor at-
mosphere produced high levels (up to 130 ppb) of HF. How-
ever, in the smoke samples, HF remained always undetected
(limit of detection (LOD): 110 ppt), but CO could be mea-
sured at concentrations up to 3.2 ppm (LOD: 250 ppb). The
2f signal amplitude (amplitude of the second harmonic) of
the CO absorption line at 2323.6 nm is shown in Fig. 9. The
measured concentrations of HF and CO are summarized in
Table 6.
Table 6 Results for the six samples measured with the NIR spectrom-
eter
Samplea CO
ppm
HF
ppb
H05 a 0.30 < 0.11
b < 0.25 < 0.11
c < 0.25 < 0.11
H06 a 3.2 < 0.11
b 2.6 < 0.11
c 1.4 < 0.11
aFor a description of the samples, see Table 4
For an overview of the MIR region from 5000 to
1000 cm−1, the spectrum of sample H01f (Table 4) was
recorded with a FTIR spectrometer. The result is shown in
Fig. 10. Water vapor and carbon dioxide saturate the absorp-
tion in several spectral regions: 1320–1910 cm−1 (water),
2240–2380 cm−1 (carbon dioxide) and 3530–3960 cm−1
(both). The absorption features in the range accessible with
the MIR DFG spectrometer are visible in the FTIR spec-
trum, too. The nine broad absorption peaks between 1000
and 1400 cm−1 can be attributed to sevoflurane [55]. No
additional species could be detected in the FTIR spectrum.
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Fig. 10 (a) Spectrum of sample H01f measured with the FTIR spec-
trometer from 800 to 4000 cm−1. Water vapor and carbon diox-
ide saturate the absorption between 1400 and 2500 cm−1 and be-
tween 3500 and 4000 cm−1. (b) Magnification of the spectral region
900–1400 cm−1. The 10P, 10R, 9P and 9R branches of CO2 are vis-
ible, as well as several absorption bands due to sevoflurane. (c) Mag-
nification of the spectral region 2900–3150 cm−1. This corresponds
to the region measurable with the DFG spectrometer. The sevoflurane
absorption peaks are visible (cf. Fig. 8)
4 Discussion
The spectra of surgical smoke samples measured with the
MIR DFG spectrometer were similar in composition to
smoke samples produced in the laboratory on animal tissue
in an earlier study [56], where water vapor, methane, ethane
and ethylene were the only detected compounds. Methane,
ethane and ethylene are relatively harmless, with recom-
mended exposure limits (REL) of 1% [57]. With concentra-
tions in the low-ppm range (Table 5), they can be considered
safe.
Concentrations of CO measured in the six surgical smoke
samples ranged from below the limit of detection (LOD) of
250 ppb up to 3.2 ppm (Table 6). This value is well be-
low the REL of 30 ppm for CO [57]. Additionally, when
CO is released from the abdominal cavity into the opera-
tion room (OR), a dilution occurs. It should be noted, how-
ever, that REL values apply to inhaled amounts: CO pro-
duced intraperitoneally is absorbed into the blood circula-
tion of the patient directly, where it causes an increase of
carboxyhemoglobin (HbCO). Esper and co-workers [58] de-
tected an increase of HbCO in patients undergoing laparo-
scopic cholecystectomy with thermocautery equipment and
linked it to a significant increase in intraperitoneal CO lev-
els (from 4.7 to 326 ppm). In a more recent study, even
higher levels of CO (>490 ppm) were detected during endo-
scopic urological resections [25]. The much lower CO con-
centrations found in the present study (≤3.2 ppm) can be at-
tributed to the lower operating temperature of the employed
vessel sealing device and to the small amount of smoke pro-
duced. In the same work, the authors also detected toluene
(5 ppb), styrene (2 ppb), xylene (2 ppb), benzene (5 ppb) and
formaldehyde (5.8 ppb). These concentrations are all below
the REL and below the LOD of our MIR DFG spectrometer.
Despite the very low LOD of only 110 ppt, hydrogen
fluoride was not detected in any of the six measured sam-
ples. Although, as laboratory experiments have shown, small
quantities could be produced in an atmosphere containing
sevoflurane vapor, hydrogen fluoride is corrosive and pene-
trates easily through porous substances. Hence, if only small
amounts are produced, it is unlikely that they will reach the
multipass cell or even the sample bag.
It is not certain how the anaesthetic sevoflurane reaches
the abdominal cavity of the patient, but, since it is very
volatile (vapor pressure: 263 mbar at 25°C), inhaled at high
(few percent) concentration and then absorbed into the pa-
tient’s bloodstream, a small amount could diffuse into the
abdominal cavity. Due to its broad and relatively strong ab-
sorption features (Fig. 8a), the presence of sevoflurane in-
terferes with the detection of other trace gases and reduces
the usefulness of preconcentration techniques. Better sen-
sitivities can be expected if sevoflurane could be removed
selectively from the gas samples. However, the presence of
a volatile anaesthetic in the abdominal cavity of the patient
is of great interest per se, since long-term exposure to low
levels of halogenated anaesthetics is thought to have unde-
sirable effects [59–61], which is why the US National In-
stitute for Occupational Safety and Health (NIOSH) recom-
mends an exposure limit of 2 ppm (8-h time-weighted av-
erage) for all halogenated anaesthetics [62]. The release of
smoke from the abdominal cavity of the patient into the OR,
because of leakage or intentionally (e.g. to restore visibility),
is therefore accompanied by the release of sevoflurane va-
por. Hence, it is an additional source of waste anaesthetic gas
(WAG) pollution [59, 60, 63–79]. Known sources of WAG
pollution include leakage from the patient’s mask, from en-
dotracheal coupling, from loose tube fittings and from air
exhaled by the patient in the recovery room. It is unknown
to which extent anaesthetic gas escaping from the patient’s
pneumoperitoneum affects the exposure of OR personnel to
WAG.
In view of the multitude of chemical compounds detected
in previous studies (Table 1), it is somewhat surprising that
only very few could be found here. On the one hand, the
sensitivity of our MIR DFG spectrometer is not compara-
ble with state-of-the-art GC-MS equipment, and the much
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better sensitivity of our NIR spectrometer comes at a price
of only being able to detect a few substances. On the other
hand, for the purpose of assessing the risk linked to surgical
smoke exposure, sub-ppm sensitivity is not strictly neces-
sary, since the RELs for most compounds are in the ppm
range. Notable exceptions are benzene and formaldehyde,
which, given their toxicity and carcinogenity, have very low
RELs. A few compounds with their RELs and LODs are
given in Table 7. None of the listed substances was detected.
Those listed in the upper part have a LOD which is lower
than the REL, and can be considered harmless. For those
in the lower part no such statement can be made: additional
measurements with more sensitive equipment are needed.
5 Conclusions
The chemical composition of surgical smoke collected dur-
ing minimally invasive surgery at the University Hospital
Zurich has been studied with a mid-infrared difference-
frequency-generation-based laser spectrometer (2817–
3144 cm−1, Fig. 1), a near-infrared spectrometer with two
distributed feedback laser diodes (for CO (2323.6 nm)
and HF (2433.1 nm) detection, Fig. 4), and a Fourier-
transform infrared (FTIR) spectrometer. The purpose of
this study was to obtain quantitative data in order to es-
tablish the risk for operation room (OR) personnel and pa-
tients in relation to the exposure to surgical smoke. The
spectroscopic measurements on the surgical smoke sam-
ples yielded the following composition: water vapor (0.27–
1.1%), methane (<0.1–9.1 ppm), ethane (<0.1–2 ppm),
ethylene (<5–10 ppm), sevoflurane (<20–450 ppm) and
carbon monoxide (<0.25–3.2 ppm) (Tables 5 and 6). Ex-
cept for the anaesthetic sevoflurane, the concentrations of
all compounds are below the recommended exposure lim-
its (RELs [57]). Due to the presence of sevoflurane in the
patient’s pneumoperitoneum, gas released into the OR is a
cause of waste anaesthetic gas (WAG) pollution. The lim-
ited number of detected compounds can be attributed to the
sensitivity of the employed spectrometers, which for most
substances lies in the ppm range. Although some very toxic
compounds need to be detected at sub-ppm concentrations,
most have RELs in the ppm range (Table 7), so that sub-ppm
sensitivity is not strictly required. For those compounds that
do require sub-ppm LODs (e.g. benzene, formaldehyde),
more research with more sensitive instruments is needed.
The composition of the samples remained stable over sev-
eral weeks after the first measurement. However, nothing
can be said about the stability during the first few hours
after sampling and before the first measurement. In con-
clusion, the only substance of relevance from a health and
safety perspective found in the present study is sevoflurane.
Notice, however, that we restricted our investigation to the
gas phase and ignored the solid (aerosol) phase.
Table 7 Limits of detection (LOD, with the MIR DFG spectrome-
ter) and recommended exposure limits (REL) for a few selected com-
pounds. Upper part: compounds which could be detected at concen-
trations below the REL (LOD < REL). Lower part: compounds which
could not be detected at or below the REL (LOD > REL)
Substance LOD
ppm
REL
ppm
Toluene 8.8 50
Styrene 11 20
Acetone 14 150
p-Xylene 6.5 100
m-Xylene 7.7 100
o-Xylene 7.6 100
Ammonia 750 20
Formaldehyde 0.78 0.3
Benzene 8.7 0.5
Acrylonitrile 150 2
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